{"status": "OK", "response": {"docs": [{"type_of_material": "Blog", "blog": [], "news_desk": null, "lead_paragraph": "The biotech drugs used to treat multiple sclerosis produce health benefits that come at an exorbitant cost, according to a new study published on Wednesday.", "headline": {"main": "Study Examines High Drug Costs vs. Benefits for M.S. Patients", "kicker": "Prescriptions"}, "abstract": "A new study finds the costs of bio-tech drugs for treating multiple sclerosis about 10 times more than what would be considered cost-effective.", "print_page": null, "word_count": 744, "_id": "4fd3a0858eb7c8105d8e5e3e", "snippet": "A new study finds the costs of bio-tech drugs for treating multiple sclerosis about 10 times more than what would be considered cost-effective.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://prescriptions.blogs.nytimes.com/2011/07/20/study-examines-high-drug-costs-vs-benefits-for-m-s-patients/", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Prices (Fares, Fees and Rates)", "name": "subject", "rank": "4"}, {"value": "Multiple Sclerosis", "name": "subject", "rank": "3"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "2"}, {"value": "News", "name": "type_of_material", "rank": "1"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "blogpost", "pub_date": "2011-07-20T16:34:34Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "National", "lead_paragraph": "A medical advisory panel suggested all health plans cover birth control under the new health care law.", "headline": {"seo": "Mandatory Contraceptive Insurance Is Urged", "main": "Panel Recommends Coverage for Contraception", "print_headline": "Panel Calling for Free-Contraceptive Coverage"}, "abstract": null, "print_page": "1", "word_count": "946", "_id": "54107c3279881060c5af815b", "snippet": "A medical advisory panel suggested all health plans cover birth control under the new health care law.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2011/07/20/health/policy/20health.html", "multimedia": [], "subsection_name": "Money & Policy", "keywords": [{"value": "Patient Protection and Affordable Care Act (2010)", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Birth Control and Family Planning", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Health Insurance and Managed Care", "is_major": "N", "rank": "3", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Robert", "lastname": "PEAR"}], "original": "By ROBERT PEAR"}, "document_type": "article", "pub_date": "2011-07-20T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Carl C. Icahn is a whirlwind. He has agitated for change at General Motors, Time Warner, Yahoo and dozens of other companies over the last decade. But Mr. Icahn is as controversial as he is ubiquitous. In his latest move, the billionaire financier made an unsolicited bid to buyClorox, an offer that was promptly rejected by the board on Monday.", "headline": {"main": "Icahn's Activism Helps Lift Some Stocks, but Others Plunge", "kicker": "DEAL PROFESSOR"}, "abstract": "Steven M Davidoff Deal Professor column says Carl C Icahn continues his controversial ways, noted by his unsolicited bid to buy Clorox, which has rekindled the long-running debate about whether investors benefit from his presence; drawing (M)", "print_page": "9", "word_count": 1038, "_id": "500906af1c22dfde670b15c2", "snippet": "Carl C. Icahn is a whirlwind. He has agitated for change at General Motors, Time Warner, Yahoo and dozens of other companies over the last decade.     But Mr. Icahn is as controversial as he is ubiquitous. In his latest move, the billionaire...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9802E1DD133CF933A15754C0A9679D8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "ICAHN, CARL C"}, {"name": "organizations", "value": "CLOROX CO"}, {"name": "subject", "value": "MERGERS, ACQUISITIONS AND DIVESTITURES"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1}], "original": "By STEVEN M. DAVIDOFF"}, "document_type": "article", "pub_date": "2011-07-20T00:00:00Z", "section_name": "Business"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Aug. 17 | Updated Carl C. Icahn is a whirlwind. He has agitated for change at General Motors, Time Warner, Yahoo and dozens of other companies over the last decade.", "headline": {"main": "Icahn's Activism Helps Lift Some Stocks, but Others Plunge", "kicker": "DEAL PROFESSOR"}, "abstract": null, "print_page": "9", "word_count": 1120, "_id": "4fd2925f8eb7c8105d86b1a8", "snippet": "Aug. 17 | Updated      Carl C. Icahn is a whirlwind. He has agitated for change at General Motors, Time Warner, Yahoo and dozens of other companies over the last decade.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9F05E3DA1F3CF933A15754C0A9679D8B63", "multimedia": [], "subsection_name": null, "keywords": [], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1}], "original": "By STEVEN M. DAVIDOFF"}, "document_type": "article", "pub_date": "2011-07-20T00:00:00Z", "section_name": "Business"}, {"type_of_material": "Blog", "blog": [], "news_desk": null, "lead_paragraph": null, "headline": {"main": "Icahn's Activism Lifts Some Stocks, but Others Plunge", "kicker": "DealBook", "print_headline": "Icahn\u2019s Activism Helps Lift Some Stocks, but Others Plunge"}, "abstract": "Carl C. Icahn's unsolicited bid to buy Clorox has rekindled the long-running debate about whether investors benefit from his presence.", "print_page": null, "word_count": "1002", "_id": "54f4e6e279881059dfb2f8c6", "snippet": "Carl C. Icahn's unsolicited bid to buy Clorox has rekindled the long-running debate about whether investors benefit from his presence.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://dealbook.nytimes.com/2011/07/19/icahns-activism-lifts-some-stocks-but-others-plunge/", "multimedia": [{"subtype": "thumbnail", "url": "images/2011/07/16/business/dbpix-people-carl-icahn/dbpix-people-carl-icahn-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2011/07/16/business/dbpix-people-carl-icahn/dbpix-people-carl-icahn-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": "Dealbook", "keywords": [], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Steven"}], "original": "By STEVEN M. DAVIDOFF"}, "document_type": "blogpost", "pub_date": "2011-07-19T20:24:33Z", "section_name": "Business Day"}, {"type_of_material": "News", "blog": [], "news_desk": "National", "lead_paragraph": "Researchers are seeking federal approval for what is believed to be the first study to examine the effects of marijuana on veterans with chronic post-traumatic stress disorder.", "headline": {"seo": "Marijuana for Post-Traumatic Stress Disorder May Be Studied", "main": "Marijuana May Be Studied for Combat Disorder", "print_headline": "Marijuana May Be Studied for Combat Disorder"}, "abstract": null, "print_page": "15", "word_count": "832", "_id": "5410762379881060c5af80e1", "snippet": "Researchers are seeking federal approval for what is believed to be the first study to examine the effects of marijuana on veterans with chronic post-traumatic stress disorder.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2011/07/19/us/19pot.html", "multimedia": [{"subtype": "thumbnail", "url": "images/2011/07/19/us/POT/POT-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2011/07/19/us/POT/POT-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Marijuana", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Post-Traumatic Stress Disorder", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Veterans", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Research", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "5", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Dan", "lastname": "FROSCH"}], "original": "By DAN FROSCH"}, "document_type": "article", "pub_date": "2011-07-19T00:00:00Z", "section_name": "U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Science Desk", "lead_paragraph": "Most doctors view pain as a symptom of an underlying problem -- treat the disease or the injury, and the pain goes away. But for large numbers of patients, the pain never goes away. In a sweeping review issued last month, the Institute of Medicine -- the medical branch of the National Academy of Sciences -- estimated that chronic pain afflicts 116 million Americans, far more than previously believed.", "headline": {"main": "Giving Chronic Pain a Medical Platform of Its Own", "kicker": "WELL"}, "abstract": null, "print_page": "5", "word_count": 849, "_id": "4fd2a0b08eb7c8105d8849c2", "snippet": "Most doctors view pain as a symptom of an underlying problem -- treat the disease or the injury, and the pain goes away.     But for large numbers of patients, the pain never goes away. In a sweeping review issued last month, the Institute of...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9A0DE5DA143CF93AA25754C0A9679D8B63", "multimedia": [], "subsection_name": null, "keywords": [], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Tara", "rank": 1, "lastname": "PARKER-POPE"}], "original": "By TARA PARKER-POPE; Join the discussion at nytimes.com/well"}, "document_type": "article", "pub_date": "2011-07-19T00:00:00Z", "section_name": "Science; Health"}, {"type_of_material": "Blog", "blog": [], "news_desk": null, "lead_paragraph": null, "headline": {"main": "Giving Chronic Pain a Medical Platform of Its Own", "kicker": "Well"}, "abstract": "The medical branch of the National Academy of Sciences estimates that 116 million Americans suffer from chronic pain, which can alter the nervous system over time.", "print_page": null, "word_count": "848", "_id": "54f4fc7879881059dfb2f8e2", "snippet": "The medical branch of the National Academy of Sciences estimates that 116 million Americans suffer from chronic pain, which can alter the nervous system over time.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://well.blogs.nytimes.com/2011/07/18/giving-chronic-pain-a-medical-platform-of-its-own/", "multimedia": [{"subtype": "xlarge", "url": "images/2011/07/19/science/19well/19well-articleLarge.jpg", "height": 369, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2011/07/19/science/19well/19well-articleLarge.jpg", "xlargeheight": "369"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2011/07/19/science/19well/19well-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2011/07/19/science/19well/19well-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Tara", "lastname": "PARKER-POPE"}], "original": "By TARA PARKER-POPE"}, "document_type": "blogpost", "pub_date": "2011-07-18T17:10:35Z", "section_name": "Health"}, {"type_of_material": "Blog", "blog": [], "news_desk": null, "lead_paragraph": "Most doctors view pain as a symptom of an underlying problem - treat the disease or the injury, and the pain goes away.", "headline": {"main": "Giving Chronic Pain a Medical Platform of Its Own", "kicker": "Well"}, "abstract": "The medical branch of the National Academy of Sciences estimates that 116 million Americans suffer from chronic pain, which can alter the nervous system over time.", "print_page": null, "word_count": 831, "_id": "4fd3a08f8eb7c8105d8e5f3e", "snippet": "The medical branch of the National Academy of Sciences estimates that 116 million Americans suffer from chronic pain, which can alter the nervous system over time.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://well.blogs.nytimes.com/2011/07/18/giving-chronic-pain-a-medical-platform-of-its-own/", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Pain", "name": "subject", "rank": "3"}, {"value": "Medicine and Health", "name": "subject", "rank": "2"}, {"value": "News", "name": "type_of_material", "rank": "1"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Tara", "lastname": "PARKER-POPE"}], "original": "By TARA PARKER-POPE"}, "document_type": "blogpost", "pub_date": "2011-07-18T17:10:35Z", "section_name": "Health"}, {"type_of_material": "Letter", "blog": [], "news_desk": "Letters", "lead_paragraph": "Readers discuss last week\u2019s Sunday Review article about antidepressants.", "headline": {"main": "Sunday Dialogue: Seeking a Path Through Depression\u2019s Landscape", "content_kicker": "Letters", "kicker": "Letters", "print_headline": "Sunday Dialogue: Seeking a Path Through Depression\u2019s Landscape", "sub": "The Letter"}, "abstract": null, "print_page": "10", "word_count": "1683", "_id": "54105d35798810138774ac46", "snippet": "Readers discuss last week\u2019s Sunday Review article about antidepressants.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2011/07/17/opinion/sunday/l17dialogue.html", "multimedia": [{"subtype": "wide", "url": "images/2011/07/17/sunday-review/0717SRletters/0717SRletters-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2011/07/17/sunday-review/0717SRletters/0717SRletters-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2011/07/17/sunday-review/0717SRletters/0717SRletters-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2011/07/17/sunday-review/0717SRletters/0717SRletters-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": "Sunday Review", "keywords": [{"value": "Antidepressants", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Depression (Mental)", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Mental Health and Disorders", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Psychiatry and Psychiatrists", "is_major": "N", "rank": "5", "name": "subject"}], "byline": [], "document_type": "article", "pub_date": "2011-07-17T00:00:00Z", "section_name": "Opinion"}], "meta": {"hits": 10, "offset": 0, "time": 56}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}